Correlation Between Soleno Therapeutics and Moleculin Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Soleno Therapeutics and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Soleno Therapeutics and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Soleno Therapeutics and Moleculin Biotech, you can compare the effects of market volatilities on Soleno Therapeutics and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Soleno Therapeutics with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Soleno Therapeutics and Moleculin Biotech.

Diversification Opportunities for Soleno Therapeutics and Moleculin Biotech

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Soleno and Moleculin is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Soleno Therapeutics and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Soleno Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Soleno Therapeutics are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Soleno Therapeutics i.e., Soleno Therapeutics and Moleculin Biotech go up and down completely randomly.

Pair Corralation between Soleno Therapeutics and Moleculin Biotech

Given the investment horizon of 90 days Soleno Therapeutics is expected to generate 0.37 times more return on investment than Moleculin Biotech. However, Soleno Therapeutics is 2.73 times less risky than Moleculin Biotech. It trades about 0.1 of its potential returns per unit of risk. Moleculin Biotech is currently generating about 0.03 per unit of risk. If you would invest  5,531  in Soleno Therapeutics on August 29, 2024 and sell it today you would earn a total of  303.00  from holding Soleno Therapeutics or generate 5.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Soleno Therapeutics  vs.  Moleculin Biotech

 Performance 
       Timeline  
Soleno Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Soleno Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Soleno Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Moleculin Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Moleculin Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Moleculin Biotech may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Soleno Therapeutics and Moleculin Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Soleno Therapeutics and Moleculin Biotech

The main advantage of trading using opposite Soleno Therapeutics and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Soleno Therapeutics position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.
The idea behind Soleno Therapeutics and Moleculin Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon